AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $231,000 | +4.5% | 15,269 | -48.1% | 0.01% | -17.6% |
| Q2 2022 | $221,000 | +106.5% | 29,440 | +93.3% | 0.02% | +30.8% |
| Q4 2021 | $107,000 | -49.3% | 15,233 | -17.9% | 0.01% | -53.6% |
| Q3 2021 | $211,000 | -37.9% | 18,543 | -12.8% | 0.03% | -75.4% |
| Q2 2021 | $340,000 | +13.3% | 21,260 | +26.6% | 0.11% | +18.8% |
| Q1 2021 | $300,000 | +79.6% | 16,790 | +36.2% | 0.10% | +100.0% |
| Q4 2020 | $167,000 | -6.2% | 12,330 | +2.0% | 0.05% | -20.0% |
| Q2 2020 | $178,000 | -3.3% | 12,090 | -11.3% | 0.06% | -23.1% |
| Q1 2020 | $184,000 | – | 13,625 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |